0.83

4.31% 0.0343

After Hours: .87 0.04 +4.82%

Abvc Biopharma Inc (ABVC)

Overview News Price History Financials Why ABVC Down? Discussions Forecast Stock Split

Abvc Biopharma Inc stock is traded at $0.83, with a volume of 94,038. It is up +4.31% in the last 24 hours and down -21.70% over the past month. ABVC BioPharma Inc is a clinical stage biopharmaceutical company focused on development of new drugs and medical devices, all of which are derived from plants. It currently has six drugs and three medical devices in development. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes. Its products include: Vitargus - ABV-1701, ABV-2001, ABV-2002, MDD ABV-1504, ADHD ABV-1505, ADHD ABV-1601, ABV-1501, ABV-1702, and ABV-1703.

Previous Close:

$0.7957

Open:

$0.84

24h Volume:

94,038

Relative Volume:

0.66

Market Cap:

$22.12M

Revenue:

$2,000

Net Income/Loss:

$-9.12M

P/E Ratio:

-2.132

EPS:

-0.3893

Net Cash Flow:

$-3.35M

1W Performance:

-6.73%

1M Performance:

-21.70%

6M Performance:

-36.64%

1Y Performance:

-73.05%

1-Day Range:

$0.81

$0.8499

1-Week Range:

$0.7069

$0.9098

52-Week Range:

$0.7069

$3.40

Abvc Biopharma Inc Stock (ABVC) Company Profile

Name

Abvc Biopharma Inc

Sector

Healthcare (1080)

Industry

Biotechnology (605)

Phone

510-668-0881

Address

44370 OLD WARM SPRINGS BLVD., FREMONT

Employee

Twitter

Next Earnings Date

2026-08-12

Latest SEC Filings

ABVC's Discussions on Twitter

Compare ABVC vs VRTX, REGN, ARGX, MRNA, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ABVC Abvc Biopharma Inc	0.83	23.72M	2,000	-9.12M	-3.35M	-0.3893
VRTX Vertex Pharmaceuticals Inc	541.69	136.93B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	794.19	85.11B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	1,023.21	64.95B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	137.99	53.23B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	207.88	45.38B	742.00K	-1.37B	-1.07B	-7.0731

Abvc Biopharma Inc Stock (ABVC) Latest News

Aug 19, 2026

ABVC (ABVC) Earnings Report: The Latest Financial Metrics Are Now Available in the Latest Session; Trading Response: Shares Finish 8.39% Up in the Latest SessionNet Income Trends - vinanet.vn

Aug 19, 2026

Aug 18, 2026

ABVC BioPharma (ABVC) Slides 5.56% to $0.85 as Micro-Cap Biotech Faces Selling PressureGap Fill Strategy - vinanet.vn

Aug 18, 2026

Aug 15, 2026

ABVC Q1 2025 Earnings: Net Loss of -$0.06 Per Share, Stock Slips 6.2%Earnings Growth Forecast - vinanet.vn

Aug 15, 2026

ABVC BioPharma (ABVC) Slips 6.2% to $0.90 as Selling Pressure Builds Near Key SupportInstitutional Buy Signals - Vinanet

Aug 15, 2026

ABVC BioPharma (ABVC) Declines 6.2% to $0.90, Testing Key SupportVolatility Smile - vinanet.vn

Aug 15, 2026

Aug 14, 2026

ACTU Stock Price and Chart — NASDAQ:ACTU - TradingView

Aug 14, 2026

Aug 12, 2026

ABVC BioPharma (ABVC) plans new equity plan and up to 6.6M-share land deal - Stock Titan

Aug 12, 2026

ABVC BIOPHARMA, INC. Q2 2026: Revenue $0 EPS $(0.03) — 10-Q Summary - TradingView

Aug 12, 2026

ABVC BioPharma (ABVC) flags going concern risk after Q2 2026 cash drain - Stock Titan

Aug 12, 2026

ABVC Biopharma Says Biokey Share Distribution Rescheduled For August 21 - TradingView

Aug 12, 2026

Form 8K ABVC Biopharma Inc For: 12 August By Investing.com - Investing.com Nigeria

Aug 12, 2026

ABVC BioPharma (ABVC) Financials 2026Income Statement and Balance Sheet - MarketBeat

Aug 12, 2026

Aug 10, 2026